leisure time -WSS

leisure time

author：hotspot 2025-09-07 04:07:04 - browse：46844

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Medicare Advantage today, explained in one chart

focus

Wikipedia

WSS

Eli Lilly, Pfizer, and others want in on the online prescription market

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Congenital heart disease patients face new threat of heart failure

Congenital heart disease patients face new threat of heart failure

What causes an itch? Researchers may have solved the mystery

The surgeon had a dilemma only a Nazi medical text could resolve

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

The cancer drug shortage isn’t new — and neither are the solutions

In diabetes hearing, Sanders takes on a new foe: food makers

Supreme Court strikes down use of affirmative action

Test for long Covid? Researchers find new clue in blood samples

Alkermes shareholders re

STAT letters to the editor on burnt

Wildfire smoke exposes gaps in outdoor worker protections

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Cancer drug shortages should be causing more outrage

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

explore

Humana cuts profit projections as Medicare Advantage costs soar

Americans' trust in science, scientist continues decline: Report

Americans' trust in science, scientist continues decline: Report

My yearlong odyssey to get my son’s ADHD medication covered

My yearlong odyssey to get my son’s ADHD medication covered

Elizabeth Holmes banned from government health programs

focus

Wikipedia

Wikipedia

focus